-0f3cff3fbc-pdf-1.webp)
-0f3cff3fbc-pdf-1.webp)
第1页 / 共19页
-0f3cff3fbc-pdf-2.webp)
第2页 / 共19页
-0f3cff3fbc-pdf-3.webp)
第3页 / 共19页
试读已结束,还剩16页,您可下载完整版后进行离线阅读
2022JPS临床实践指南:胰腺癌(概要)此内容为付费资源,请付费后查看
赞助会员一年免费赞助会员三年免费
付费资源
© 版权声明
1、当您下载文档后,您只拥有了使用权限,并不意味着购买了版权,文档只能用于自身学习参考,不得用于其他商业用途(如 [转卖]进行直接盈利或[编辑后售卖]进行间接盈利)。
2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,请自行鉴别。
3、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请“联系客服处理”。
4、内容来源于网络,仅限用于学习和研究目的,版权争议与本站无关。您必须在下载后的24个小时之内,从您的电脑中彻底删除上述内容。如有侵权请与我们联系处理。
THE END
International Journal of Clinical Oncologyhttp5/doi.org/10.1007/s10147-023-02317-xSPECIAL ARTICLEClinical Practice Guidelines for Pancreatic Cancer 2022 from the JapanPancreas Society:a synopsisTakuji Okusaka.Masafumi Nakamura2.Masahiro Yoshida3.Masayuki Kitano4.Yoshinori Ito5.Nobumasa Mizuno5.Keiji Hanada?.Masato Ozaka.Chigusa Morizane'.Yoshifumi Takeyamaon behalf of theCommittee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas SocietyReceived:19 October 2022/Accepted:14 February 2023©The Author(s)2023AbstractObjectives Clinical Practice Guidelines for Pancreatic Cancer was first published in 2006 by the Japan Pancreas Society,and revised in 2009,2013,2016,and 2019.In July 2022,Clinical Practice Guidelines for Pancreatic Cancer was newlyrevised in Japanese.Methods For this revision,we developed an entirely new guideline according to the Minds Manual for Guideline Develop-ment 2020,which includes the concepts of GRADE-Grading Recommendations Assessment,Development,and Evalu-ation,to enable a better understanding of the current guidelines.Patients and the public were actively involved in both thedevelopment and implementation of the guideline.Results The guideline includes algorithms for diagnosis,treatment,chemotherapy,and precision medicine of pancreaticcancer,and addresses 7 subjects:diagnosis,surgical therapy,adjuvant therapy,radiation therapy,chemotherapy,stent therapy,and supportive palliative medical care.It includes 73 clinical questions and 112 statements.The statements correspondto the clinical questions,evidence levels,recommendation strengths,and agreement rates.Conclusions This guideline represents the most standard clinical and practical management guideline available until datein Japan.This is the English synopsis of the Clinical Practice Guidelines for Pancreatic Cancer 2022 in Japanese,and is anattempt to disseminate the Japanese guideline worldwide to introduce the Japanese approach to the clinical management ofpancreatic cancer.Keywords Pancreatic cancer.Clinical guidelines.Japan Pancreas Society.Minds.GRADE systemAbbreviationsEUSEndoscopic ultrasonographyBRBorderline resectableEUS-FNAEndoscopic ultrasonography-fine-needleCTComputed tomographyaspirationERCPEndoscopic retrogradeJPSJapan Pancreas Societycholangiopancreatography☒Takuji Okusaka5Department of Radiation Oncology,Showa Universitytokusaka@ncc.go.jpSchool of Medicine,Tokyo,Japan6Department of Hepatobiliary and Pancreatic Oncology,Department of Gastroenterology.Aichi Cancer CenterNational Cancer Center Hospital,5-1-1 Tsukiji,Chuo-ku,Hospital,Nagoya,JapanTokyo 104-0045,Japan7Department of Gastroenterology.JA Onomichi GeneralHospital,Onomichi,JapanDepartment of Surgery and Oncology.Graduate Schoolof Medical Sciences,Kyushu University.Fukuoka,JapanHepato-Biliary-Pancreatic Medicine Department,Cancer3Department of Hepato-Biliary-Pancreatic and GI Surgery,Institute Hospital,Tokyo,JapanInternational University of Health and Welfare,Ichikawa,Depart